New injection aims to improve breathing in COPD patients
NCT ID NCT07519499
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called XKH001 in 75 people with moderate to severe COPD. The drug is given as an injection to see if it can improve lung function and reduce symptoms over 24 to 48 weeks. Participants are randomly assigned to receive either the drug or a placebo, and neither they nor their doctors will know which they receive. The goal is to find a new way to manage COPD and help people breathe easier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••